These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9926898)

  • 21. Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
    Zemmrich C; Lüders S; Gansz A; Sturm CD; Fimmers R; Nadal J; Schmieder RE; Schrader J; Bramlage P
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):815-9. PubMed ID: 24102831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Safety and antihypertensive efficacy of the dihydropyridine calcium antagonist Amlodipine besylate--results from an observational study in 9,672 patients].
    Keck M; Sauerbrey-Wullkopf N; Regourd E; Clemens A
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):115-21. PubMed ID: 15662901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension.
    Weber MA; White WB; Sica D; Bakris GL; Cao C; Roberts A; Kupfer S
    Blood Press Monit; 2014 Apr; 19(2):90-7. PubMed ID: 24445723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System.
    Testa MA; Turner RR; Simonson DC; Krafcik MB; Calvo C; Luque-Otero M
    J Hypertens; 1998 Dec; 16(12 Pt 1):1839-47. PubMed ID: 9869019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of amlodipine dosing for conversion of nifedipine extended-release to amlodipine in the treatment of hypertension.
    Yamreudeewong W; Halverson VJ; Lower DL; Kilpatrick DM; Enlow AM; Montopoli G
    Ann Pharmacother; 1999 Jan; 33(1):7-10. PubMed ID: 9972377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient inhibition of the development of cardiac remodeling by a long-acting calcium antagonist amlodipine.
    Yamazaki T; Komuro I; Zou Y; Kudoh S; Shiojima I; Mizuno T; Hiroi Y; Nagai R; Yazaki Y
    Hypertension; 1998 Jan; 31(1):32-8. PubMed ID: 9449387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
    Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
    Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heart rate variability in patients with hypertension and type 2 diabetes treated with long acting calcium antagonists].
    Lopatin IuM; Kirakozov DA; Statsenko ME
    Kardiologiia; 2003; 43(5):33-6. PubMed ID: 12891237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, double-blind, crossover comparison of amlodipine and valsartan in african-americans with hypertension using 24-hour ambulatory blood pressure monitoring.
    Maciejewski S; Mohiuddin SM; Packard KA; Mooss AN; Reyes AP; Aryana A; Hilleman DE
    Pharmacotherapy; 2006 Jul; 26(7):889-95. PubMed ID: 16803420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
    Karpov IuA
    Kardiologiia; 2005; 45(12):87-92. PubMed ID: 16353053
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction of cardiovascular structural changes by nifedipine GITS in essential hypertensive patients.
    Agabiti-Rosei E; Zulli R; Muiesan ML; Salvetti M; Rizzoni D; Corbellini C; Monteduro C
    Blood Press; 1998 May; 7(3):160-9. PubMed ID: 9758086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG; Bakris GL
    Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
    Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus.
    Lopez LM; Thorman AD; Mehta JL
    Am J Cardiol; 1990 Nov; 66(17):1269-71. PubMed ID: 2146871
    [No Abstract]   [Full Text] [Related]  

  • 37. The efficacy and safety of arotinolol combined with a different calcium channel blocker in the treatment of Chinese patients with essential hypertension: a one-year follow-up study.
    Fang H; Chen W; Liu X; Xu W
    Clin Exp Hypertens; 2014; 36(8):590-5. PubMed ID: 24678807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged antihypertensive effect of amlodipine: a prospective double-blind randomized study.
    Biston P; Mélot C; Degaute JP; Clement D; Quoidbach A
    Blood Press; 1999; 8(1):43-8. PubMed ID: 10412882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
    Praxis (Bern 1994); 2004 Oct; 93(42):1748. PubMed ID: 15529964
    [No Abstract]   [Full Text] [Related]  

  • 40. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.